Who invested in Centrexion Therapeutics?
Centrexion Therapeutics's investors include New Enterprise Associates and Eli Lilly.
Who invested in Centrexion Therapeutics
Funding summaryUpdated 26 Oct 2026
$41Mraised across 1 round since 2020, from 1 source
- Latest round
- Venture, $41MOct 2020
- Investors
- 2
The rounds
- Oct 2020Venture$41M
Source recordedSEC filing: $14M sold, first sale Jan 2021
Founders and team
From Centrexion Therapeutics's own website: 7 on the team.
- Jeffrey B. KindlerChief Executive Officer
- Jonathan GuerrieroChief Development Operations Officer
- Mike WardChief Financial Officer/Chief Operations Officer
- Colin HillDirector
- Joseph R. SwedishDirector
- Medical AdvisorBoard of Directors
- Shawn TomaselloDirector
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Centrexion Therapeutics
How much has Centrexion Therapeutics raised?
Centrexion Therapeutics has raised $41M across 1 round since 2020.
When did Centrexion Therapeutics last raise?
Centrexion Therapeutics's most recent round was a Venture of $41M in Oct 2020.
What was Centrexion Therapeutics's biggest round?
Its most recent round, $41M in Oct 2020, is also its largest on record.
Who backed Centrexion Therapeutics first?
Centrexion Therapeutics's first round on record, in Oct 2020, was backed by New Enterprise Associates and Eli Lilly.
What stage is Centrexion Therapeutics at?
Centrexion Therapeutics's latest named round is a Venture, in Oct 2020.
Companies like Centrexion Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.